Show simple item record Walia, Baljit S. en_US 2007-05-18T19:59:38Z 2007-05-18T19:59:38Z 1999-08-01T00:00:00Z en_US
dc.description.abstract In the present study, we have investigated the role of matrix metalloproteinases (MMP) during the development of volume overload induced moderate heart failure. Furthermore, we have tested whether the renin angiotensin system (RAS) or specifically the activation of AT1 receptors is involved in the progression to cardiac hypertrophy and heart failure caused by volume overload. This was achieved by the use of losartan, an AT1 receptor antagonist. Surgically induced aorto-venous fistula (AV shunt: AVF) is the model of volume overloaded heart failure used in these investigations. Animals were divided into three groups; a sham-operated control group, an AV shunt group and an AV shunt group treated with losartan. Hemodynamic and anatomical studies were performed at 8 weeks after the shunt surgery while all other studies were performed at 1 and 8 week post AV shunt induction. To examine whether MMP and MMP inhibitory protein (TIMP) activities are altered in this model of heart failure, zymography and reverse zymography were performed respectively using ventricular tissue samples. Immunoreactive MMP protein abundance was determined by Western blot analysis. To evaluate the role of angiotensin II, AT1 antagonism was applied to experimental animals (losartan:40 mg/kg/day). (Abstract shortened by UMI.) en_US
dc.format.extent 6304052 bytes
dc.format.extent 184 bytes
dc.format.mimetype application/pdf
dc.format.mimetype text/plain
dc.language en en_US
dc.language.iso en_US
dc.rights info:eu-repo/semantics/openAccess
dc.title Matrix metalloproteinase activation in heart failure due to volume-overloa and the effect of AT|1 receptor blockade en_US
dc.type info:eu-repo/semantics/masterThesis Physiology en_US Master of Science (M.Sc.) en_US

Files in this item

This item appears in the following Collection(s)

Show simple item record

View Statistics